| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9225562 | Journal of Allergy and Clinical Immunology | 2005 | 8 Pages |
Abstract
These results suggest that after exposure to antigens, human MCs may induce sputum production via release of amphiregulin. Therefore, amphiregulin may be a new target molecule for treatment of overproduction of sputum in bronchial asthma.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Shigeru DDS, PhD, Hironori MD, PhD, Takeshi MD, PhD, Hirohisa MD, PhD, Yoshimichi MD, PhD,